“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Researchers have developed a test that spots early signs of Alzheimer's disease. Rather than looking for amyloid-beta plaques ...

Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, shares findings from a survey on colorectal cancer care ...

Researchers have developed a novel analytical method for tracking disease progression in patients that shows great potential ...

Chemistry researchers at Case Western Reserve University have identified specific markers that could pave the way for new ...

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

On Saturday, hundreds of people swore off Manhattan’s bottomless brunch scene to attend an all-day longevity summit to learn ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the TD Cowen's 45th Annual Health Care Conference on ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...

The Company expects to receive aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting ...

Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases.